top of page
LIfT BioSciences announces data demonstrating potent killing of pancreatic cancer tumouroids
IMAN demonstrated potent direct killing of a patient derived pancreatic ductal adenocarcinoma tumouroid model IMAN is the world’s first...
May 4, 2023
LIfT BioSciences announces breakthrough preclinical data demonstrating dual mode of action
LIfT BioSciences announces breakthrough preclinical data demonstrating the dual mode of action commonly believed necessary for curing solid
Mar 21, 2023
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership
GMP N-LIfT being produced for forthcoming clinical trials LONDON, UK and MUNICH, Germany – February 16th, 2023. LIfT BioSciences, a...
Feb 16, 2023
bottom of page